Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Arthur M. Cohen & Associates LLC

Arthur M. Cohen & Associates LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,340 shares of the medical equipment provider’s stock after purchasing an additional 522 shares during the period. Intuitive Surgical makes up approximately 1.0% of Arthur M. Cohen & Associates LLC’s investment portfolio, making the stock its 18th biggest position. Arthur M. Cohen & Associates LLC’s holdings in Intuitive Surgical were worth $5,397,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the third quarter worth $38,000. Finally, DT Investment Partners LLC increased its stake in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The business has a fifty day moving average of $539.54 and a 200-day moving average of $497.69. The stock has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Piper Sandler restated an “overweight” rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.